299 related articles for article (PubMed ID: 28331826)
21. Adenocarcinomas with predominant ground-glass opacity: correlation of morphology and molecular biomarkers.
Aoki T; Hanamiya M; Uramoto H; Hisaoka M; Yamashita Y; Korogi Y
Radiology; 2012 Aug; 264(2):590-6. PubMed ID: 22653188
[TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread.
Chung JH; Choe G; Jheon S; Sung SW; Kim TJ; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2009 Dec; 4(12):1490-5. PubMed ID: 19844187
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor mutation accelerates radiographic progression in lung adenocarcinoma presented as a solitary ground-glass opacity.
Lu Q; Ma Y; An Z; Zhao T; Xu Z; Chen H
J Thorac Dis; 2018 Nov; 10(11):6030-6039. PubMed ID: 30622774
[TBL] [Abstract][Full Text] [Related]
24. Identification of preoperative prediction factors of tumor subtypes for patients with solitary ground-glass opacity pulmonary nodules.
Li M; Wang Y; Chen Y; Zhang Z
J Cardiothorac Surg; 2018 Jan; 13(1):9. PubMed ID: 29343293
[TBL] [Abstract][Full Text] [Related]
25. Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity.
Yoshida Y; Kokubu A; Suzuki K; Kuribayashi H; Tsuta K; Matsuno Y; Kusumoto M; Kanai Y; Asamura H; Hirohashi S; Shibata T
Jpn J Clin Oncol; 2007 Dec; 37(12):907-12. PubMed ID: 18089646
[TBL] [Abstract][Full Text] [Related]
26. Ground glass opacity resection extent assessment trial
Li H; Wang Y; Chen Y; Zhong C; Fang W
Front Oncol; 2023; 13():1052796. PubMed ID: 36741022
[TBL] [Abstract][Full Text] [Related]
27. Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth.
Kobayashi Y; Mitsudomi T; Sakao Y; Yatabe Y
Ann Oncol; 2015 Jan; 26(1):156-161. PubMed ID: 25361983
[TBL] [Abstract][Full Text] [Related]
28. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions.
Asamura H; Suzuki K; Watanabe S; Matsuno Y; Maeshima A; Tsuchiya R
Ann Thorac Surg; 2003 Oct; 76(4):1016-22. PubMed ID: 14529977
[TBL] [Abstract][Full Text] [Related]
29. CT-guided Hookwire localization before video-assisted thoracoscopic surgery for solitary ground-glass opacity dominant pulmonary nodules: radiologic-pathologic analysis.
Huang HZ; Wang GZ; Xu LC; Li GD; Wang Y; Wang YH; He XH; Li WT
Oncotarget; 2017 Dec; 8(64):108118-108129. PubMed ID: 29296228
[TBL] [Abstract][Full Text] [Related]
30. Predicting EGFR mutation status in lung adenocarcinoma presenting as ground-glass opacity: utilizing radiomics model in clinical translation.
Cheng B; Deng H; Zhao Y; Xiong J; Liang P; Li C; Liang H; Shi J; Li J; Xiong S; Lai T; Chen Z; Wu J; Qian T; Huan W; Ng MTA; He J; Liang W
Eur Radiol; 2022 Sep; 32(9):5869-5879. PubMed ID: 35348863
[TBL] [Abstract][Full Text] [Related]
31. Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography.
Nakata M; Sawada S; Saeki H; Takashima S; Mogami H; Teramoto N; Eguchi K
Ann Thorac Surg; 2003 May; 75(5):1601-5; discussion 1605-6. PubMed ID: 12735586
[TBL] [Abstract][Full Text] [Related]
32. Computed tomography and pathology evaluation of lung ground-glass opacity.
Yu H; Liu S; Zhang C; Li S; Ren J; Zhang J; Xu W
Exp Ther Med; 2018 Dec; 16(6):5305-5309. PubMed ID: 30542487
[TBL] [Abstract][Full Text] [Related]
33. Pitfalls of Computed Tomography in the Coronavirus 2019 (COVID-19) Era: A New Perspective on Ground-Glass Opacities.
Mehrabi S; Fontana S; Mambrin F; Nguyen HQ; Righi E; Tacconelli E; Mansueto G
Cureus; 2020 May; 12(5):e8151. PubMed ID: 32550070
[TBL] [Abstract][Full Text] [Related]
34. Pregnancy may have little influence on ground-glass opacities suspected for lung adenocarcinoma.
Bai J; Deng C; Fu F; Li D; Ma Z; Ma X; Zhang Y; Chen H
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1383-1389. PubMed ID: 35445333
[TBL] [Abstract][Full Text] [Related]
35. High-resolution computed tomography features and CT-guided microcoil localization of subcentimeter pulmonary ground-glass opacities: radiological processing prior to video-assisted thoracoscopic surgery.
Wang ZX; Li L; Zhang Z; Wang GH; Kong DM; Wang XD; Wang F
J Thorac Dis; 2018 May; 10(5):2676-2684. PubMed ID: 29997929
[TBL] [Abstract][Full Text] [Related]
36. Computer-aided diagnosis of lung cancer: definition and detection of ground-glass opacity type of nodules by high-resolution computed tomography.
Okada T; Iwano S; Ishigaki T; Kitasaka T; Hirano Y; Mori K; Suenaga Y; Naganawa S
Jpn J Radiol; 2009 Feb; 27(2):91-9. PubMed ID: 19373538
[TBL] [Abstract][Full Text] [Related]
37. Ground-Glass Opacity Lung Nodules in the Era of Lung Cancer CT Screening: Radiology, Pathology, and Clinical Management.
Pedersen JH; Saghir Z; Wille MM; Thomsen LH; Skov BG; Ashraf H
Oncology (Williston Park); 2016 Mar; 30(3):266-74. PubMed ID: 26984222
[TBL] [Abstract][Full Text] [Related]
38. Computed tomography characteristics of lung adenocarcinomas with epidermal growth factor receptor mutation: A propensity score matching study.
Suh YJ; Lee HJ; Kim YJ; Kim KG; Kim H; Jeon YK; Kim YT
Lung Cancer; 2018 Sep; 123():52-59. PubMed ID: 30089595
[TBL] [Abstract][Full Text] [Related]
39. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.
Cai G; Wong R; Chhieng D; Levy GH; Gettinger SN; Herbst RS; Puchalski JT; Homer RJ; Hui P
Cancer Cytopathol; 2013 Sep; 121(9):500-7. PubMed ID: 23495083
[TBL] [Abstract][Full Text] [Related]
40. Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I/II lung adenocarcinoma.
Zou J; Lv T; Zhu S; Lu Z; Shen Q; Xia L; Wu J; Song Y; Liu H
Thorac Cancer; 2017 May; 8(3):260-270. PubMed ID: 28383802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
